Josh Hawley proposes a new law to prohibit the abortion pill mifepristone
Sen. Josh Hawley Proposes Bill to Ban Mifepristone On Tuesday, Senator Josh Hawley from Missouri introduced new legislation aimed at revoking the FDA approval of mifepristone, a widely used abortion medication. This proposed bill extends from a previous one he presented last year, which sought to ban the drug completely and empower women to sue […]
Senator Josh Hawley urges federal action and supervision on mifepristone.
Sen. Hawley Seeks Stricter Regulation on Mifepristone Senator Josh Hawley from Missouri is urging for increased oversight on the abortion drug mifepristone, insisting that it’s time for Congress to enact what he calls fundamental safety measures. “The troubling fact is that the number of abortions in the U.S. has risen since Roe v. Wade was […]
Live Action calls for the Trump administration to halt the approval of mifepristone
Live Action Urges Trump Administration to Act on Mifepristone The pro-life organization Live Action is pressing the Trump administration to intervene in the way mifepristone, commonly known as the “abortion pill,” is distributed and reported. They are concerned about the potential dangers associated with this medication. On Thursday, the group plans to hold a press […]
Missouri files a lawsuit against the FDA regarding the approval of generic mifepristone, citing safety concerns.
Missouri Attorney General Expands Legal Action Against Mail-Order Abortion Pills On Thursday, Missouri Attorney General Katherine Hannaway announced an expansion of the state’s legal efforts against mail-order abortion pills, specifically targeting the new generic version of mifepristone. Hannaway argues that these medications are leading to serious hospitalizations due to “life-threatening complications” and are entering the […]
Regulatory Body Approves New Generic Form of Abortion Medication Mifepristone
FDA Approves New Generic Abortion Drug, Sparking Controversy The US Food and Drug Administration (FDA) recently approved a new generic version of mifepristone, a drug commonly used in abortion procedures. This decision has ignited significant backlash from conservative groups and anti-abortion activists. The FDA’s endorsement concerns the generic variant of mifepristone, which is the first […]
Foundation calls for RFK Jr. to respond about the safety reduction of mifepristone
Senate Finance Committee Hearing on Abortion Drug Safety The Restoration of America Foundation (ROAF) is urging the Senate Finance Committee to hold Health and Human Services Secretary Robert F. Kennedy Jr. accountable during a hearing scheduled for Thursday at 10 AM. The foundation is questioning the recent removal of safety protocols related to the abortion […]
22 Republican attorneys general call for safety measures for mifepristone
Republican Attorney Generals Urge Restoration of Mifepristone Safety Protocols In a recent letter, over 20 Republican Attorneys General have urged the Trump administration to reinstate safety measures for the abortion drug Mifepristone, citing serious risks to women’s health. According to a letter acquired by Fox News Digital, 22 attorneys filed suit against Health and Human […]
Makary: No immediate plans to alter mifepristone access
Mifepristone Policy Review by FDA Director In a recent conversation, Food and Drug Administration Director Marty McCurry expressed that he approached the review of mifepristone, a medication used to terminate pregnancies up to ten weeks, without any preconceptions. He emphasized the importance of staying open-minded and listening to various perspectives when making decisions. “Right now, […]
FDA head promises to look into mifepristone
The Director of the Food and Drug Administration, Marty McCurry, expressed his intention to review the abortion medication Mifepristone in correspondence with Senator Josh Hawley (R-Mo.). “As with all medications, the FDA is continuously monitoring safety data from Mifepristone for medical termination in early pregnancy,” McCurry noted. He emphasized his commitment to engaging with professional […]
Reproductive rights advocates oppose Kennedy’s review of mifepristone
Reproductive rights advocates are voicing concerns about HHS Director Robert F. Kennedy Jr.’s recent actions. During a Senate hearing, Kennedy instructed the FDA to reassess the medication, referencing findings from a study conducted by the Ethics and Public Policy Center (EPPC), a conservative think tank. Critics argue that Kennedy is using questionable data to undermine […]